Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: SLDB

Solid Biosciences Inc.

Healthcare | Biotechnology

No licensed closing price on file for SLDB. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Solid Biosciences Inc. (NASDAQ: SLDB) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 16:48 UTC.

Key facts

Revenue Trend

FY2021: $14M$14MFY2021FY2022: $8M$8MFY2022
Annual Revenue · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-06
  • 2026-10-06DirectorRestricted Stock UnitsOption exercise-3,440—
  • 2026-10-06DirectorOption exercise3,440—
  • 2026-07-07DirectorRestricted Stock UnitsOption exercise-3,440—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →
For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for SLDB and 5,000+ tickers.

Create a free account — keep SLDB
For your agent
GET /api/data?ticker=SLDB

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt